[1]
|
钟久昌. 血管紧张素转换酶2: 新型冠状病毒肺炎炎症风暴的“导火索”和“灭火器” [J]. 中华高血压杂志, 2020, 28(3): 213-215.
|
[2]
|
杨晨茜, 瞿娇, 刘怡彤, 孟思伟, 王冰琳, 冯美卿, 孙洋. 新型冠状病毒肺炎的免疫失衡及干预策略[J]. 中国药理学通报, 2020, 36(4): 445-453.
|
[3]
|
唐劲松, 宣春, 林景涛, 张二盈, 钟孟如, 邓娟. C-反应蛋白、白介素-6及降钙素原检测在新冠肺炎中的临床意义[J]. 实用医学杂志, 2020, 36(7): 839-841.
|
[4]
|
Patel, U., Malik, P., Mehta, D., Shah, D., Kelkar, R., Pinto, C., et al. (2020) Early Epidemiological Indicators, Outcomes, and Interventions of COVID-19 Pandemic: A Systematic Review. Journal of Global Health, 10, Article ID: 020506. https://doi.org/10.7189/jogh.10.020506
|
[5]
|
Han, H., Ma, Q., Li, C., Liu, R., Zhao, L., Wang, W., et al. (2020) Profiling Serum Cytokines in COVID-19 Patients Reveals IL-6 and IL-10 Are Disease Severity Predictors. Emerging Microbes & Infections, 9, 1123-1130.
https://doi.org/10.1080/22221751.2020.1770129
|
[6]
|
Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z., et al. (2020) COVID-19 in a Designated Infectious Diseases Hospital Outside Hubei Province, China. Allergy, 75, 1742-1752. https://doi.org/10.1111/all.14309
|
[7]
|
Turnquist, C., Ryan, B.M., Horikawa, I., Harris, B.T. and Harris, C.C. (2020) Cytokine Storms in Cancer and COVID-19. Cancer Cell, 38, 598-601. https://doi.org/10.1016/j.ccell.2020.09.019
|
[8]
|
赵勇, 谢敏, 李会敏, 徐敏芳, 夏方妹, 肖红慧. 2型糖尿病合并新型冠状病毒肺炎患者的临床特征及中医病机分析[J]. 湖北中医药大学学报, 2020, 22(4): 100-104.
|
[9]
|
Elnour, A.A., Don, J., Yousif, I., Gnana, K., Abdi, S., Alhajri, N., et al. (2020) The Early Mortality Rate of People Infected with Coronavirus (COVID-2019) in Wuhan, China: Review of Three Retrospective Studies. Journal of Pharmacy and BioAllied Sciences, 12, 223-233. https://doi.org/10.4103/jpbs.JPBS_282_20
|
[10]
|
Biswas, M., Rahaman, S., Biswas, T.K., Haque, Z. and Ibrahim, B. (2020) Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis. Intervirology, 9, 36-47.
https://doi.org/10.1159/000512592
|
[11]
|
魏东, 李颖, 刘蕾, 王毅. 纤维支气管镜吸痰联合抗感染对重症肺炎患者治疗效果及PCT、IL-6、CRP水平的影响[J]. 中国医刊, 2018, 53(4): 394-397.
|
[12]
|
唐智敏, 高湲, 杨世忠. 血清suPAR、D-二聚体及IL-6在重症肺炎患者中的表达及临床意义[J]. 临床肺科杂志, 2018, 23(9): 1691-1695.
|
[13]
|
Rodrigues, K.F., Pietrani, N.T. and Bosco, A.A. (2017) IL-6, TNF-α, and IL-10 Levels/Polymorphisms and Their Association with Type 2 Diabetes Mellitus and Obesity in Brazilian Individuals. Archives of Endocrinology and Metabolism, 61, 438-446. https://doi.org/10.1590/2359-3997000000254
|
[14]
|
Sangoi, M.B., Carvalho, J.A.M., Guarda, N.S., Duarte, T., Duarte, M.M.M.F., Premaor, M.O., et al. (2019) Association between Urinary Levels of Interleukin-6, Interleukin-10 and Tumor Necrosis Factor-Alpha with Glomerular and Tubular Damage Indicators in Patients with Type 2 Diabetes. Clinical Laboratory, 65.
https://doi.org/10.7754/Clin.Lab.2019.190410
|
[15]
|
Canecki-Varžić, S., Prpić-Križevac, I., Mihaljević, S., Bilić-Ćurčić, I., Alkhamis, T., Wagner, J., et al. (2018) Association Between Interleukin-10 Gene (-1082g/A) Polymorphism and Type 2 Diabetes, Diabetes-Related Traits, and Microvascular Complications in the Croatian Population. Acta Clinica Croatica, 57, 71-81.
https://doi.org/10.20471/acc.2018.57.01.08
|
[16]
|
Borowska, M., Dworacka, M., Wesołowska, A., Winiarska, H., Krzyżagórska, E. and Dworacki, G. (2016) The Impact of Pharmacotherapy of Type 2 Diabetes Mellitus on IL-1beta, IL-6 and IL-10 Secretion. Pharmacology, 97, 189-194.
https://doi.org/10.1159/000443897
|
[17]
|
Boyko, V.V. and Riga, A.S. (2020) Type 2 Diabetes Mellitus—IL-8 and IL-10 Profile in Patients with Intraabdominal Postoperative Abscesses. Wiadomości Lekarskie, 73, 220-223. https://doi.org/10.36740/WLek202002102
|
[18]
|
Costa, F.F., Rosário, W.R., Ribeiro Farias, A.C., de Souza, R.G., Duarte Gondim, R.S. and Barroso, W.A. (2020) Metabolic Syndrome and COVID-19: An Update on the Associated Comorbidities and Proposed Therapies. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14, 809-814. https://doi.org/10.1016/j.dsx.2020.06.016
|
[19]
|
Yang, A.P., Li, H.M., Tao, W.Q., Yang, X.J., Wang, M., Yang, W.J. and Liu, J.P. (2020) Infection with SARS-CoV-2 Causes Abnormal Laboratory Results of Multiple Organs in Patients. Aging, 12, 10059-10069.
https://doi.org/10.18632/aging.103255
|
[20]
|
Ouyang, Y., Yin, J., Wang, W., Shi, H., Shi, Y., Xu, B., et al. (2020) Downregulated Gene Expression Spectrum and Immune Responses Changed during the Disease Progression in Patients with COVID-19. Clinical Infectious Diseases, 71, 2052-2060. https://doi.org/10.1093/cid/ciaa462
|